Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04603183
Title ABemaciclib, ET +/- paclItaxel in aGgressive HR+/HER2- MBC trIaL (ABIGAIL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications

Her2-receptor negative breast cancer

Therapies

Abemaciclib + Fulvestrant + Letrozole

Paclitaxel

Age Groups: adult | senior
Covered Countries ITA | ESP


No variant requirements are available.